Baur A - Search Results

1

Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis.

Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Mentrup B, Baur A, Koehrle J, Wiersinga WM. Boelen A, et al. Among authors: baur a. Eur J Endocrinol. 2004 Oct;151(4):497-502. doi: 10.1530/eje.0.1510497. Eur J Endocrinol. 2004. PMID: 15476451

2

Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness.

Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Baur A, Köhrle J, Wiersinga WM. Boelen A, et al. Among authors: baur a. Horm Metab Res. 2004 Feb;36(2):101-6. doi: 10.1055/s-2004-814219. Horm Metab Res. 2004. PMID: 15002060

3

Effects of proinflammatory cytokines on anterior pituitary 5'-deiodinase type I and type II.

Baur A, Bauer K, Jarry H, Köhrle J. Baur A, et al. J Endocrinol. 2000 Dec;167(3):505-15. doi: 10.1677/joe.0.1670505. J Endocrinol. 2000. PMID: 11115778

4

Type 1 deiodinase is stimulated by iodothyronines and involved in thyroid hormone metabolism in human somatomammotroph GX cells.

Baur A, Köhrle J. Baur A, et al. Eur J Endocrinol. 1999 Apr;140(4):367-70. doi: 10.1530/eje.0.1400367. Eur J Endocrinol. 1999. PMID: 10097258

5

Expression of 5'-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas.

Baur A, Buchfelder M, Köhrle J. Baur A, et al. Eur J Endocrinol. 2002 Aug;147(2):263-8. doi: 10.1530/eje.0.1470263. Eur J Endocrinol. 2002. PMID: 12153750

6

3,5-diiodo-L-thyronine stimulates type 1 5'deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro.

Baur A, Bauer K, Jarry H, Köhrle J. Baur A, et al. Endocrinology. 1997 Aug;138(8):3242-8. doi: 10.1210/endo.138.8.5333. Endocrinology. 1997. PMID: 9231774

7

Selenoproteins are expressed in fetal human osteoblast-like cells.

Dreher I, Schütze N, Baur A, Hesse K, Schneider D, Köhrle J, Jakob F. Dreher I, et al. Among authors: baur a. Biochem Biophys Res Commun. 1998 Apr 7;245(1):101-7. doi: 10.1006/bbrc.1998.8393. Biochem Biophys Res Commun. 1998. PMID: 9535791

8

Differential effects of potassium channel blockers on neurohypophysial release of oxytocin and vasopressin. Evidence for frequency-dependent interaction with the endogenous opioid inhibition of oxytocin release.

Racké K, Altes U, Baur AM, Hobbach HP, Jost D, Schäfer J, Wammack R. Racké K, et al. Among authors: baur am. Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):560-6. doi: 10.1007/BF00179330. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2854213

9

Tetraethylammonium ions and 4-aminopyridine prevent opioid inhibition of neurohypophysial oxytocin release.

Racké K, Altes U, Baur AM, Jost D, Schäfer J. Racké K, et al. Among authors: baur am. Brain Res. 1987 Dec 15;436(2):371-3. doi: 10.1016/0006-8993(87)91682-9. Brain Res. 1987. PMID: 2829994

10

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.

Hamm CA, Asbach P, Pöhlmann A, Schoots IG, Kasivisvanathan V, Henkel TO, Johannsen M, Speck T, Baur ADJ, Haas M, Collettini F, Penzkofer T, Savic LJ, Konietschke F, Weißbach L, Hamm B, König F, Cash H. Hamm CA, et al. Among authors: baur adj. JAMA Oncol. 2024 Dec 12. doi: 10.1001/jamaoncol.2024.5497. Online ahead of print. JAMA Oncol. 2024. PMID: 39666360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters